Author Correction: The landscape of d16HER2 splice variant expression across HER2-positive cancers

Sci Rep. 2020 Apr 24;10(1):7210. doi: 10.1038/s41598-020-63942-4.

¹ Department of the Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
² Department of Oncology and Hemato-oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
³ Faculty of Medicine, Oncology and Hemato-Oncology Department, Università degli Studi di Milano, Milan, Italy.
⁴ Department of Oncology, University of Turin, Turin, Italy.
⁵ Candiolo Cancer Institute, FPO - IRCCS - Candiolo (TO), Turin, Italy.
⁶ Unit of Medical Oncology, Azienda Ospedaliera-Universitaria Pisana, Pisa, Italy.
⁷ Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
⁸ Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. serenella.pupa@istitutotumori.mi.it.

^# Contributed equally.

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.